Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-12

Clinical Trial Update: Magnesium Sulfate Effect Following the Reversal of Neuromuscular Blockade Induced by Rocuronium With Sugammadex [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of magnesium sulfate after reversal of rocuronium-induced neuromuscular blockade with sugammadex.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Magnesium sulfate (magnesium sulfate)
  • Rocuronium (rocuronium bromide)
  • Sugammadex (sugammadex)

Snippet

Sponsor: Universidade Federal do Rio de Janeiro | Conditions: Neuromuscular Blockade | Phase 4 | Status: COMPLETED